Future Capital
Europe, Hessen, Germany, Frankfurt
Description
Future Capital invests in companies engaged in the life sciences and chemistry, including nanotechnology and material sciences.
Investor Profile
Future Capital has backed more than 17 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 12% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series D rounds (top funding stages).
- Majority of deals are located in China, Germany, United States.
- Strong thematic focus on Biotechnology, Software, Artificial Intelligence (AI).
Stage Focus
- Series A (29%)
- Series B (18%)
- Series D (12%)
- Angel (12%)
- Private Equity (6%)
- Seed (6%)
- Series Unknown (6%)
- Series E (6%)
- Series C (6%)
Country Focus
- China (65%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Germany (29%)
- United States (6%)
Industry Focus
- Biotechnology
- Software
- Artificial Intelligence (Ai)
- Biopharma
- Pharmaceutical
- Health Care
- Information Technology
- Enterprise
- Machine Learning
- Automotive
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
